Integra Lifesciences

US · IART #3240 by market cap

13.00 -0.32 -2.40%

Live - 5344 symbols - heartbeat 222s ago · 2026-10-07 19:54

After-hours 13.00 0.00%

Market cap: 1.01B
P/E (TTM): -144.44
P/B: 0.97
EPS: -6.74
Div yield: 0.00%
52W pos: 36%

Reader sentiment Are you bullish or bearish on IART?

Anonymous reader poll. Unscientific, not investment advice.

About Integra Lifesciences

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

Founded: 1989
CEO: Mr. Stuart M. Essig, PhD
Employees: 4,427
Headquarters: Princeton, New Jersey, United States of America
Fiscal year end: 12-31
Website: integralife.com

Company profile

Exchange: US
Symbol: IART
Market-cap rank: #3240
Market cap: 1.01B
Float cap: 762.47M
Shares out: 77.77M
Float shares: 58.65M

Sectors & themes

Medical Devices Brain-Computer Interface Global medical industry Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.